Linfeng Zhan

788 total citations
9 papers, 492 citations indexed

About

Linfeng Zhan is a scholar working on Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Linfeng Zhan has authored 9 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Linfeng Zhan's work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). Linfeng Zhan is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). Linfeng Zhan collaborates with scholars based in China, Saudi Arabia and Oman. Linfeng Zhan's co-authors include Zhenwei Pan, Yanjie Lu, Yin Yuan, Shenjian Luo, Fei Sun, Baofeng Yang, Ti Yang, Zhiguo Wang, Hao Wu and Haixia Zhu and has published in prestigious journals such as Scientific Reports, European Journal of Pharmacology and Environmental Microbiology.

In The Last Decade

Linfeng Zhan

9 papers receiving 480 citations

Peers

Linfeng Zhan

MB

CR

CCM

SURGE

PHEOH

Juan Xu China

Emily Koeck United States

Manli Yu China

Chengfu Cao China

Zhe Su China

Samantha Sevilla United States

Meili Pei China

Jiaxin Shi China

Shalaimaiti Shali China

Samira Kalayinia Iran

Juan Xu China

Linfeng Zhan

255 ×0.8

MB

153 ×0.6

CR

256 ×2.1

CCM

40 ×0.8

SURGE

12 ×0.4

PHEOH

Citations per year, relative to Linfeng Zhan Linfeng Zhan (= 1×) peers Juan Xu

Countries citing papers authored by Linfeng Zhan

Since Specialization

Citations

This map shows the geographic impact of Linfeng Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfeng Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfeng Zhan more than expected).

Fields of papers citing papers by Linfeng Zhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linfeng Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfeng Zhan. The network helps show where Linfeng Zhan may publish in the future.

Co-authorship network of co-authors of Linfeng Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Linfeng Zhan. A scholar is included among the top collaborators of Linfeng Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linfeng Zhan. Linfeng Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fan, Yong, Zheying Min, Zhenglai Ma, et al.. (2021). Generation of human blastocyst-like structures from pluripotent stem cells. Cell Discovery. 7(1). 81–81. 103 indexed citations

2.

Zhan, Linfeng, Qi Zhang, Lu Zhao, et al.. (2021). LncRNA-6395 promotes myocardial ischemia-reperfusion injury in mice through increasing p53 pathway. Acta Pharmacologica Sinica. 43(6). 1383–1394. 13 indexed citations

3.

Liu, Wei, Chaojie Yang, Fangyan Chen, et al.. (2021). Environmental contamination with SARS‐CoV ‐2 in COVID ‐19 hospitals in Wuhan, China, 2020. Environmental Microbiology. 23(12). 7373–7381. 6 indexed citations

4.

Jin, Xuexin, Yuan Jiang, Genlong Xue, et al.. (2019). Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice. European Journal of Pharmacology. 857. 172444–172444. 24 indexed citations

5.

Luo, Shenjian, Jifan Zhang, Yin Yuan, et al.. (2019). lncRNA H19 Alleviated Myocardial I/RI via Suppressing miR-877-3p/Bcl-2-Mediated Mitochondrial Apoptosis. Molecular Therapy — Nucleic Acids. 17. 297–309. 86 indexed citations

6.

Zhuang, Yuting, Tingting Li, Wanqi Yang, et al.. (2019). Involvement of lncR-30245 in Myocardial Infarction–Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor-γ–Mediated Connective Tissue Growth Factor Signalling Pathway. Canadian Journal of Cardiology. 35(4). 480–489. 13 indexed citations

7.

Sun, Fei, Yuting Zhuang, Haixia Zhu, et al.. (2019). LncRNA PCFL promotes cardiac fibrosis via miR-378/GRB2 pathway following myocardial infarction. Journal of Molecular and Cellular Cardiology. 133. 188–198. 44 indexed citations

8.

Wu, Hao, Haixia Zhu, Yuting Zhuang, et al.. (2019). LncRNA ACART protects cardiomyocytes from apoptosis by activating PPAR‐γ/Bcl‐2 pathway. Journal of Cellular and Molecular Medicine. 24(1). 737–746. 26 indexed citations

9.

Du, Yue, You Shu, Ming Gao, et al.. (2017). MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium. Scientific Reports. 7(1). 42657–42657. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact